| Year |
Citation |
Score |
| 2007 |
Burks JK, Summers MD, Braunagel SC. BV/ODV-E26: a palmitoylated, multifunctional structural protein of Autographa californica nucleopolyhedrovirus. Virology. 361: 194-203. PMID 17169392 DOI: 10.1016/J.Virol.2006.11.007 |
0.568 |
|
| 2006 |
Saksena S, Summers MD, Burks JK, Johnson AE, Braunagel SC. Importin-alpha-16 is a translocon-associated protein involved in sorting membrane proteins to the nuclear envelope. Nature Structural & Molecular Biology. 13: 500-8. PMID 16715095 DOI: 10.1038/Nsmb1098 |
0.386 |
|
| 1999 |
Braunagel SC, Burks JK, Rosas-Acosta G, Harrison RL, Ma H, Summers MD. Mutations within the Autographa californica nucleopolyhedrovirus FP25K gene decrease the accumulation of ODV-E66 and alter its intranuclear transport. Journal of Virology. 73: 8559-70. PMID 10482609 DOI: 10.1128/Jvi.73.10.8559-8570.1999 |
0.53 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Zhang C, Zhang MX, Shen YH, Burks JK, Zhang Y, Wang J, LeMaire SA, Yoshimura K, Aoki H, Coselli JS, Wang XL. TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 1760-7. PMID 17478756 DOI: 10.1161/ATVBAHA.107.144881 |
0.268 |
|
| 2015 |
Ruvolo PP, Ruvolo VR, Jacamo R, Burks JK, Zeng Z, Qiu Y, Yoo SY, Pan R, Hail N, Konopleva M, Calin G, Kornblau SM, Andreeff M. Tumor Suppressor Role for B55 alpha PP2A Isoform in AML Clinical Lymphoma Myeloma and Leukemia. 15: S180-S181. DOI: 10.1016/J.Clml.2015.04.024 |
0.253 |
|
| 2015 |
Ruvolo P, Qiu Y, Ruvolo V, Wang R, Zeng Z, Burks J, Pan R, Hail N, McQueen T, Yoo S, Kornblau SM, Andreeff M. Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment Blood. 126: 1198-1198. DOI: 10.1182/Blood.V126.23.1198.1198 |
0.23 |
|
| 2018 |
Ruvolo PP, Ruvolo VR, Burks JK, Qiu Y, Wang RY, Shpall EJ, Mirandola L, Hail N, Zeng Z, McQueen T, Daver N, Post SM, Chiriva-Internati M, Kornblau SM, Andreeff M. Role of MSC-derived galectin 3 in the AML microenvironment. Biochimica Et Biophysica Acta. PMID 29655803 DOI: 10.1016/J.Bbamcr.2018.04.005 |
0.214 |
|
| 2022 |
Radnaa E, Richardson L, Goldman B, Burks JK, Baljinnyam T, Vora N, Zhang HJ, Bonney EA, Han A, Menon R. Stress Signaler p38 Mitogen-Activated Kinase Activation: A Cause for Concern? Clinical Science (London, England : 1979). PMID 36250628 DOI: 10.1042/CS20220491 |
0.197 |
|
| 2022 |
Millian DE, Saldarriaga OA, Wanninger T, Burks JK, Rafati YN, Gosnell J, Stevenson HL. Cutting-Edge Platforms for Analysis of Immune Cells in the Hepatic Microenvironment-Focus on Tumor-Associated Macrophages in Hepatocellular Carcinoma. Cancers. 14. PMID 35454766 DOI: 10.3390/cancers14081861 |
0.195 |
|
| 2008 |
Zhang W, Konopleva M, Burks J, Dywer K, Schober W, Yang J, McQueen T, Hung M, Andreeff M. 266 POSTER Apoptosis induction in acute myeloid leukemia by inhibition of MEK and MDM2 is strongly associated with the BH3-only proteins Puma and Bim European Journal of Cancer Supplements. 6: 86-87. DOI: 10.1016/S1359-6349(08)72200-6 |
0.181 |
|
| 2014 |
Ruvolo PP, Ruvolo VR, Jacamo R, Burks JK, Zeng Z, Duvvuri SR, Zhou L, Qiu Y, Coombes KR, Zhang N, Yoo SY, Pan R, Hail N, Konopleva M, Calin G, et al. The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochimica Et Biophysica Acta. 1843: 1969-77. PMID 24858343 DOI: 10.1016/J.Bbamcr.2014.05.006 |
0.177 |
|
| 2014 |
Han L, Rowinsky E, Brooks C, Zal T, Zal MA, Burks JK, Zhou J, Ciurea SO, Alatrash G, Cortes JE, Kantarjian HM, Andreeff M, Ravandi F, Konopleva M. Anti-Leukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody-Conjugate in Acute Myeloid Leukemia Blood. 124: 981-981. DOI: 10.1182/blood.V124.21.981.981 |
0.155 |
|
| 2024 |
Zhao M, Wang T, Gleber-Netto FO, Chen Z, McGrail DJ, Gomez JA, Ju W, Gadhikar MA, Ma W, Shen L, Wang Q, Tang X, Pathak S, Raso MG, Burks JK, et al. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature Communications. 15: 180. PMID 38167338 DOI: 10.1038/s41467-023-44239-2 |
0.155 |
|
| 2008 |
Zhang C, Zhang MX, Shen YH, Burks JK, Li XN, LeMaire SA, Yoshimura K, Aoki H, Matsuzaki M, An FS, Engler DA, Matsunami RK, Coselli JS, Zhang Y, Wang XL. Role of NonO-histone interaction in TNFalpha-suppressed prolyl-4-hydroxylase alpha1. Biochimica Et Biophysica Acta. 1783: 1517-28. PMID 18439917 DOI: 10.1016/j.bbamcr.2008.03.011 |
0.153 |
|
| 2016 |
Zeng J, Soragni A, Ishizawa J, Ruvolo V, Benton CB, McQueen T, Ruvolo P, Qi Y, Su X, Burks J, Eisenberg DS, Andreeff M. Targeting Aggregation of Wilde-Type p53 and Mutant p53 with ReACp53 As a Novel Therapeutic Concept for AML Blood. 128: 3944-3944. DOI: 10.1182/Blood.V128.22.3944.3944 |
0.143 |
|
| 2011 |
Ruvolo PP, Zhou L, Watt JC, Ruvolo VR, Burks JK, Jiffar T, Kornblau S, Konopleva M, Andreeff M. Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells. Journal of Cellular Biochemistry. 112: 1696-707. PMID 21360576 DOI: 10.1002/Jcb.23090 |
0.139 |
|
| 2013 |
Kojima K, Kornblau SM, Ruvolo V, Dilip A, Duvvuri S, Davis RE, Zhang M, Wang Z, Coombes KR, Zhang N, Qiu YH, Burks JK, Kantarjian H, Shacham S, Kauffman M, et al. Prognostic impact and targeting of CRM1 in acute myeloid leukemia. Blood. 121: 4166-4174. PMID 23564911 DOI: 10.1182/Blood-2012-08-447581 |
0.138 |
|
| 2010 |
Zhang W, Konopleva M, Burks JK, Dywer KC, Schober WD, Yang JY, McQueen TJ, Hung MC, Andreeff M. Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim. Cancer Research. 70: 2424-34. PMID 20215498 DOI: 10.1158/0008-5472.Can-09-0878 |
0.137 |
|
| 2019 |
Han L, Zhang Q, Dail M, Shi C, Cavazos A, Ruvolo VR, Zhao Y, Kim E, Rahmani M, Mak DH, Jin SS, Chen J, Phillips DC, Bottecelli Koller P, Jacamo R, ... Burks JK, et al. Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models. Haematologica. PMID 31123034 DOI: 10.3324/Haematol.2018.205534 |
0.134 |
|
| 2023 |
Jia Y, Zhang W, Basyal M, Chang KH, Ostermann L, Burks JK, Ly C, Mu-Mosley H, Zhang Q, Han X, Fogler WE, Magnani JL, Lesegretain A, Zal AA, Zal T, et al. FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML. Leukemia. PMID 37085610 DOI: 10.1038/s41375-023-01897-x |
0.13 |
|
| 2019 |
Andreeff M, Zeng J, Soragni A, Ruvolo V, Carter BZ, Ishizawa J, Burks JK, Eisenberg D. Targeting Misfolded p53 and p53 Aggregation to Overcome Resistance to Apoptosis in Acute Myeloid Leukemia Blood. 134: 3786-3786. DOI: 10.1182/Blood-2019-130900 |
0.129 |
|
| 2016 |
Carter BZ, Mak PY, Chen Y, Mak DH, Mu H, Jacamo R, Ruvolo V, Arold ST, Ladbury JE, Burks JK, Kornblau S, Andreeff M. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network. Oncotarget. PMID 26956049 DOI: 10.18632/oncotarget.7911 |
0.124 |
|
| 2020 |
Sarkar A, Stellrecht CM, Vangapandu HV, Ayres M, Kaipparettu BA, Park JH, Balakrishnan K, Burks JK, Pandita TK, Hittelman WN, Neelapu SS, Gandhi V. Ataxia telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma. Haematologica. PMID 32029507 DOI: 10.3324/Haematol.2019.234385 |
0.124 |
|
| 2008 |
Fiegl M, Samudio IJ, Dwyer KC, Burks J, Fritsche H, Mnjoyan ZH, Andreeff M. CXCR4 Expression and Biological Activity Is Dependent on Oxygen Partial Pressure in Acute Myeloid Leukemia. Blood. 112: 938-938. DOI: 10.1182/Blood.V112.11.938.938 |
0.122 |
|
| 2013 |
Han L, Zeng Z, Qiu P, Jorgensen JL, Mak DH, Burks JK, McQueen T, Ravandi F, Roboz GJ, Kantarjian HM, Kornblau SM, Guzman ML, Andreeff M, Konopleva M. Single-Cell Mass Cytometry Reveals Phenotypic and Functional Heterogeneity In Acute Myeloid Leukemia At Diagnosis and In Remission Blood. 122: 1311-1311. DOI: 10.1182/Blood.V122.21.1311.1311 |
0.121 |
|
| 2019 |
Yokoi A, Villar-Prados A, Oliphint PA, Zhang J, Song X, De Hoff P, Morey R, Liu J, Roszik J, Clise-Dwyer K, Burks JK, O'Halloran TJ, Laurent LC, Sood AK. Mechanisms of nuclear content loading to exosomes. Science Advances. 5: eaax8849. PMID 31799396 DOI: 10.1126/Sciadv.Aax8849 |
0.118 |
|
| 2014 |
Mak PY, Mak DH, Mu H, Shi Y, Ruvolo P, Ruvolo V, Jacamo R, Burks JK, Wei W, Huang X, Kornblau SM, Andreeff M, Carter BZ. Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML. Apoptosis : An International Journal On Programmed Cell Death. 19: 698-707. PMID 24337870 DOI: 10.1007/s10495-013-0954-z |
0.116 |
|
| 2023 |
Fukuda Y, Kim SH, Bustos MA, Cho SN, Roszik J, Burks JK, Kim H, Hoon DSB, Grimm EA, Ekmekcioglu S. Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion. Cancer Research Communications. 3: 1397-1408. PMID 37529399 DOI: 10.1158/2767-9764.CRC-23-0210 |
0.116 |
|
| 2019 |
Dharmaraj N, Piotrowski SL, Huang C, Newton JM, Golfman LS, Hanoteau A, Koshy ST, Li AW, Pulikkathara MX, Zhang B, Burks JK, Mooney DJ, Lei YL, Sikora AG, Young S. Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape. Oncoimmunology. 8: e1568809. PMID 30906661 DOI: 10.1080/2162402X.2019.1568809 |
0.114 |
|
| 2020 |
Pourebrahim R, Montoya RH, Alaniz Z, Ostermann LB, Ayoub E, Lin PP, Burks JK, Andreeff M. Mdm2 Haplo-Insufficiency in Hematopoietic and Mesenchymal Progenitor Cells Results in Cell Death Blood. 136: 10-10. DOI: 10.1182/blood-2020-142662 |
0.114 |
|
| 2009 |
Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z, Andreeff M. CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood. 113: 1504-12. PMID 18957686 DOI: 10.1182/Blood-2008-06-161539 |
0.111 |
|
| 2022 |
Fukuda Y, Bustos MA, Cho SN, Roszik J, Ryu S, Lopez VM, Burks JK, Lee JE, Grimm EA, Hoon DSB, Ekmekcioglu S. Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma. Cell Death & Disease. 13: 117. PMID 35121729 DOI: 10.1038/s41419-022-04552-y |
0.106 |
|
| 2012 |
Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. Plos One. 7: e30563. PMID 22363446 DOI: 10.1371/Journal.Pone.0030563 |
0.106 |
|
| 2020 |
Muftuoglu M, Alaniz Z, Mak D, Lin AJ, Burks JK, Carter BZ, Andreeff M. High-Dimensional Single-Cell Proteomic Analysis Reveals Therapeutic Vulnerabilities in Relapsed/Refractory AML By Concomitant Analysis of Cell Surface Antigens, Signaling Pathways and Anti-Apoptotic Proteins Blood. 136: 26-26. DOI: 10.1182/blood-2020-143432 |
0.105 |
|
| 2021 |
Bommi PV, Bowen CM, Reyes-Uribe L, Wu W, Katayama H, Rocha P, Parra ER, Francisco-Cruz A, Ozcan Z, Tosti E, Willis JA, Wu H, Taggart MW, Burks JK, Lynch PM, et al. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells. Cancer Research. 81: 2760-2773. PMID 34003775 DOI: 10.1158/0008-5472.CAN-20-2896 |
0.104 |
|
| 2020 |
Montoya RH, Pourebrahim R, Alaniz Z, Ostermann LB, Burks JK, Andreeff M. Osterix Marks a Distinct Population of Circulatory Bone Marrow Mesenchymal Stem Cells That Is Increased upon Oncogenic Stress Blood. 136: 1-1. DOI: 10.1182/blood-2020-142713 |
0.103 |
|
| 2015 |
Han L, Qiu P, Zeng Z, Jorgensen JL, Mak DH, Burks JK, Schober W, McQueen TJ, Cortes J, Tanner SD, Roboz GJ, Kantarjian HM, Kornblau SM, Guzman ML, Andreeff M, et al. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 87: 346-56. PMID 25598437 DOI: 10.1002/Cyto.A.22628 |
0.101 |
|
| 2018 |
Han L, Qiu P, Jorgensen JL, Mak D, Burks JK, McQueen T, Zeng Z, Ravandi F, Roboz GJ, Kantarjian HM, Kornblau SM, Andreeff M, Guzman ML, Konopleva MY. Single-Cell Mass Cytometry Characterizes Phenotypic and Functional Heterogeneity in Acute Myeloid Leukemia at Diagnosis, in Remission and Relapse Blood. 132: 912-912. DOI: 10.1182/Blood-2018-99-111970 |
0.1 |
|
| 2023 |
Pourebrahim R, Heinz Montoya R, Alaniz Z, Ostermann L, Lin PP, Liu B, Ayoub E, Burks JK, Andreeff M. Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage. Cell Death & Disease. 14: 371. PMID 37353528 DOI: 10.1038/s41419-023-05844-7 |
0.099 |
|
| 2012 |
Ruvolo PP, Jacamo R, Ruvolo VR, Burks JK, Battula VL, McQueen T, Konopleva M, Kornblau SM, Garzon R, Croce CM, Andreeff M. Exosomes Mediate Communication Between the Microenvironment and Leukemic Cells in Acute Myeloid Leukemia Blood. 120: 3469-3469. DOI: 10.1182/Blood.V120.21.3469.3469 |
0.099 |
|
| 2017 |
Mansfield JR, Guest PC, Burks J. Phenotyping Multiple Subsets of Immune Cells In Situ in Formalin-Fixed, Paraffin-Embedded Tissue Sections. Advances in Experimental Medicine and Biology. 974: 327-338. PMID 28353253 DOI: 10.1007/978-3-319-52479-5_32 |
0.098 |
|
| 2016 |
Ruvolo PP, Ruvolo VR, Benton CB, AlRawi A, Burks JK, Schober W, Rolke J, Tidmarsh G, Hail N, Eric Davis R, Andreeff M. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. Biochimica Et Biophysica Acta. 1863: 562-71. PMID 26704388 DOI: 10.1016/J.Bbamcr.2015.12.008 |
0.098 |
|
| 2023 |
Pourebrahim R, Montoya RH, Alaniz Z, Ostermann L, Lin PP, Liu B, Ayoub E, Burks JK, Andreeff M. Mdm2/p53 levels in bone marrow mesenchymal stromal cells is essential for maintaining the hematopoietic niche in response to DNA damage. Research Square. PMID 36909480 DOI: 10.21203/rs.3.rs-2544760/v1 |
0.097 |
|
| 2010 |
Kojima K, Burks JK, Arts J, Andreeff M. The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemias. Molecular Cancer Therapeutics. 9: 2545-57. PMID 20736344 DOI: 10.1158/1535-7163.Mct-10-0337 |
0.097 |
|
| 2019 |
Carter BZ, Mak PY, Wang X, Tao W, Ruvolo V, Mak D, Mu H, Burks JK, Andreeff M. An ARC-regulated IL1β/Cox-2/PGE2/β-catenin/ARC circuit controls leukemia-microenvironment interactions and confers drug resistance in AML. Cancer Research. PMID 30674535 DOI: 10.1158/0008-5472.CAN-18-0921 |
0.096 |
|
| 2021 |
Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers. 13. PMID 33917869 DOI: 10.3390/cancers13081777 |
0.093 |
|
| 2020 |
Batth IS, Meng Q, Wang Q, Torres KE, Burks J, Wang J, Gorlick R, Li S. Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis. Bmc Cancer. 20: 715. PMID 32736533 DOI: 10.1186/S12885-020-07203-7 |
0.093 |
|
| 2021 |
Najem H, Marisetty A, Horbinski C, Long J, Huse JT, Glitza Oliva IC, Ferguson SD, Kumthekar PU, Wainwright DA, Chen P, Lesniak MS, Burks JK, Heimberger AB. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Frontiers in Immunology. 12: 745893. PMID 34691054 DOI: 10.3389/fimmu.2021.745893 |
0.092 |
|
| 2021 |
Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, ... ... Burks JK, et al. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biology. 47: 102132. PMID 34619528 DOI: 10.1016/j.redox.2021.102132 |
0.092 |
|
| 2022 |
Li H, Wang Y, Lin K, Venkadakrishnan VB, Bakht M, Shi W, Meng C, Zhang J, Tremble K, Liang X, Song JH, Feng X, Van V, Deng P, Burks JK, et al. CHD1 promotes sensitivity to Aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2. Cancer Research. PMID 35771632 DOI: 10.1158/0008-5472.CAN-22-0631 |
0.091 |
|
| 2019 |
Kannan S, Aitken MJL, Herbrich SM, Golfman LS, Hall MG, Mak DH, Burks JK, Song G, Konopleva M, Mullighan CG, Chandra J, Zweidler-McKay PA. Anti-Leukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics. PMID 31227645 DOI: 10.1158/1535-7163.MCT-18-0706 |
0.086 |
|
| 2024 |
Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, et al. Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature Communications. 15: 1821. PMID 38418901 DOI: 10.1038/s41467-024-45916-6 |
0.083 |
|
| 2022 |
Imanishi M, Cheng H, Kotla S, Deswal A, Le NT, Chini E, Ko KA, Samanthapudi VSK, Lee LL, Herrmann J, Xu X, Reyes-Gibby C, Yeung SJ, Schadler KL, Yusuf SW, ... ... Burks JK, et al. Radiation therapy induces immunosenescence mediated by p90RSK. Frontiers in Cardiovascular Medicine. 9: 988713. PMID 36426217 DOI: 10.3389/fcvm.2022.988713 |
0.082 |
|
| 2016 |
Li L, Muftuoglu M, Chen H, Mak D, Gokdemir E, Shaim H, Burks J, Daher M, Imahashi N, Mendt Vilchez MC, Basar R, Marin D, Champlin RE, Shpall EJ, Rezvani K. Cytomegalovirus Reactivation Shapes NK Cells Diversity Following Allogeneic Hematopoietic Stem Cell Transplantation Blood. 128: 4588-4588. DOI: 10.1182/blood.v128.22.4588.4588 |
0.081 |
|
| 2018 |
Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, ... ... Burks JK, et al. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 7: e1412909. PMID 29632728 DOI: 10.1080/2162402X.2017.1412909 |
0.081 |
|
| 2021 |
Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, ... ... Burks JK, et al. ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature Cancer. 2: 1372-1386. PMID 35121903 DOI: 10.1038/s43018-021-00260-2 |
0.08 |
|
| 2018 |
Swaminathan M, Morita K, Yuanqing Y, Wang F, Burks JK, Gumbs C, Little L, Tippen S, Thornton R, Coyle M, Zhang J, Song X, DiNardo CD, Jabbour EJ, Kadia TM, et al. Clinical Heterogeneity of AML Is Associated with Mutational Heterogeneity Blood. 132: 5240-5240. DOI: 10.1182/Blood-2018-99-117287 |
0.08 |
|
| 2021 |
Carstens JL, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews KM, Rao A, Burks JK, Rhim AD, Kalluri R. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Reports. 35: 108990. PMID 33852841 DOI: 10.1016/j.celrep.2021.108990 |
0.079 |
|
| 2023 |
Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N, Post SM, Deng Q, Sun H, Harmanci AO, ... Burks JK, et al. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunology Research. PMID 37163233 DOI: 10.1158/2326-6066.CIR-22-0961 |
0.077 |
|
| 2017 |
McCarthy RL, Mak DH, Burks JK, Barton MC. Rapid monoisotopic cisplatin based barcoding for multiplexed mass cytometry. Scientific Reports. 7: 3779. PMID 28630464 DOI: 10.1038/S41598-017-03610-2 |
0.076 |
|
| 2023 |
Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N, Post SM, Deng Q, Sun H, Harmanci AO, ... Burks JK, et al. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunology Research. OF1-OF18. PMID 37285177 DOI: 10.1158/2326-6066.CIR-22-0961 |
0.076 |
|
| 2023 |
Abe JI, Imanishi M, Li S, Zhang A, Ko KA, Samanthapudi VSK, Lee LL, Bojorges AP, Gi YJ, Hobbs BP, Deswal A, Herrmann J, Lin SH, Chini EN, Shen YH, ... ... Burks JK, et al. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis. Circulation Research. PMID 37264926 DOI: 10.1161/CIRCRESAHA.122.322017 |
0.075 |
|
| 2024 |
Ferri-Borgogno S, Burks JK, Seeley EH, McKee TD, Stolley DL, Basi AV, Gomez JA, Gamal BT, Ayyadhury S, Lawson BC, Yates MS, Birrer MJ, Lu KH, Mok SC. Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses. Cancers. 16. PMID 38473208 DOI: 10.3390/cancers16050846 |
0.075 |
|
| 2019 |
Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 178: 795-806.e12. PMID 31398337 DOI: 10.1016/J.Cell.2019.07.008 |
0.074 |
|
| 2019 |
Lara OD, Krishnan S, Wang Z, Corvigno S, Zhong Y, Lyons Y, Dood R, Hu W, Qi L, Liu J, Coleman RL, Westin SN, Fleming ND, Cristini V, Rao A, ... Burks J, et al. Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma. Scientific Reports. 9: 17589. PMID 31772388 DOI: 10.1038/S41598-019-53872-1 |
0.074 |
|
| 2008 |
Ramsay AG, Xing D, Decker WK, Burks JK, Wierda WG, Gribben JG, Shpall EJ. Compared to Adult Peripheral Blood T Cells, Cord Blood T Cells Show Enhanced Immunological Recognition of Chronic Lymphocytic Leukemia Tumor Cells. Blood. 112: 2333-2333. DOI: 10.1182/blood.v112.11.2333.2333 |
0.071 |
|
| 2009 |
Serda RE, Gu J, Burks JK, Ferrari K, Ferrari C, Ferrari M. Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 75: 752-60. PMID 19610127 DOI: 10.1002/Cyto.A.20769 |
0.07 |
|
| 2010 |
Xing D, Ramsay AG, Gribben JG, Decker WK, Burks JK, Munsell M, Li S, Robinson SN, Yang H, Steiner D, Shah N, McMannis JD, Champlin RE, Hosing C, Zweidler-McKay PA, et al. Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 684-96. PMID 20664358 DOI: 10.1097/CJI.0b013e3181e475e9 |
0.068 |
|
| 2020 |
Lee S, Zhao L, Rojas C, Bateman NW, Yao H, Lara OD, Celestino J, Morgan MB, Nguyen TV, Conrads KA, Rangel KM, Dood RL, Hajek RA, Fawcett GL, Chu RA, ... ... Burks JK, et al. Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer. Cell Reports. 31: 107502. PMID 32294438 DOI: 10.1016/J.Celrep.2020.03.066 |
0.068 |
|
| 2023 |
Zhang J, Dai H, Huo L, Burks JK, McGrail DJ, Lin SY. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway. Journal For Immunotherapy of Cancer. 11. PMID 37907220 DOI: 10.1136/jitc-2023-007560 |
0.066 |
|
| 2022 |
Chandra V, McAllister F, Burks JK. Cytometry of Mass for Murine Immunoprofiling. Methods in Molecular Biology (Clifton, N.J.). 2435: 129-137. PMID 34993943 DOI: 10.1007/978-1-0716-2014-4_9 |
0.065 |
|
| 2023 |
Ferri-Borgogno S, Zhu Y, Sheng J, Burks JK, Gomez JA, Wong KK, Wong STC, Mok SC. Spatial transcriptomics depict ligand-receptor crosstalk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors. Cancer Research. PMID 36787106 DOI: 10.1158/0008-5472.CAN-22-1821 |
0.064 |
|
| 2013 |
Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, ... ... Burks J, et al. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. Plos One. 8: e76781. PMID 24204673 DOI: 10.1371/journal.pone.0076781 |
0.064 |
|
| 2022 |
Wang X, Semba T, Manyam GC, Wang J, Shao S, Bertucci F, Finetti P, Krishnamurthy S, Phi LTH, Pearson T, Van Laere SJ, Burks JK, Cohen EN, Reuben JM, Yang F, et al. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science Advances. 8: eabn7983. PMID 36525493 DOI: 10.1126/sciadv.abn7983 |
0.062 |
|
| 2021 |
Muftuoglu M, Li L, Liang S, Mak D, Lin AJ, Fang J, Burks JK, Chen K, Andreeff M. Extended live-cell barcoding approach for multiplexed mass cytometry. Scientific Reports. 11: 12388. PMID 34117319 DOI: 10.1038/s41598-021-91816-w |
0.061 |
|
| 2018 |
Yuan B, Ly S, Nguyen K, Tran V, Maldonado K, Kinglsey C, Burks JK, Zhou X, deCrombrugghe B, Andreeff M, Battula VL. Acute Myeloid Leukemia Expands Osteoprogenitor Rich Niche in the Bone Marrow but Resorbs Mature Bone Causing Osteopenia/Osteoporosis in Animal Models Blood. 132: 86-86. DOI: 10.1182/Blood-2018-99-117258 |
0.061 |
|
| 2023 |
Amit M, Baruch E, Nagarajan P, Gleber-Netto F, Rao X, Xie T, Akhter S, Adewale A, Islam S, Mattson B, Ferrarotto R, Wong M, Davies M, Jindal S, Basu S, ... ... Burks J, et al. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade. Research Square. PMID 37503252 DOI: 10.21203/rs.3.rs-3161761/v1 |
0.06 |
|
| 2024 |
Marques-Piubelli ML, Kumar B, Basar R, Panowski S, Srinivasan S, Norwood K, Prashad S, Szenes V, Balakumaran A, Arandhya A, Lu W, Khan K, Duenas D, McAllen S, Gomez JA, ... Burks JK, et al. Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents. Virchows Archiv : An International Journal of Pathology. PMID 38388965 DOI: 10.1007/s00428-024-03741-8 |
0.059 |
|
| 2010 |
Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, Clise-Dwyer K, Wang RY, Zhang W, Yuan X, Lu H, Caldwell L, Andreeff M. Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 3: 83-95. PMID 21209776 DOI: 10.1007/S12307-010-0041-8 |
0.057 |
|
| 2016 |
Muftuoglu M, Li L, Chen H, Mak D, Gokdemir E, Shaim H, Burks J, Basar R, Imahashi N, Mendt MC, Daher M, Marin D, Wierda WG, Jain N, Keating MJ, et al. Mass Cytometry Reveals Heterogeneity in the Exhaustion Profile of T-Cells in Chronic Lymphocytic Leukemia and the CD4:CD8 Ratio May be a Reliable Predictor of CD8+ T Cell Compartment "Fitness" Blood. 128: 353-353. DOI: 10.1182/blood.V128.22.353.353 |
0.056 |
|
| 2020 |
Saldarriaga OA, Freiberg B, Krishnan S, Rao A, Burks J, Booth AL, Dye B, Utay N, Ferguson M, Akil A, Yi M, Beretta L, Stevenson HL. Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease. Hepatology Communications. 4: 708-723. PMID 32363321 DOI: 10.1002/hep4.1494 |
0.055 |
|
| 2016 |
Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA, Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, Joo J, Kim SC, Yun JS, Na KJ, Choi YL, ... ... Burks JK, et al. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer. Gut. PMID 27507904 DOI: 10.1136/gutjnl-2015-311238 |
0.055 |
|
| 2023 |
de Sousa LG, McGrail DJ, Lazar Neto F, Li K, Marques-Piubelli ML, Ferri-Borgogno S, Dai H, Mitani Y, Spardy Burr N, Cooper ZA, Kinneer K, Cortez MA, Lin SY, Bell D, El-Naggar A, ... Burks J, et al. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37256648 DOI: 10.1158/1078-0432.CCR-23-0514 |
0.054 |
|
| 2020 |
Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, De Los Santos MC, Anfossi S, Shimizu M, Shah MY, Ling H, ... ... Burks JK, et al. The Long Noncoding RNA CCAT2 induces chromosomal instability through BOP1 - AURKB signaling. Gastroenterology. PMID 32805281 DOI: 10.1053/J.Gastro.2020.08.018 |
0.054 |
|
| 2018 |
Jiang X, Mak PY, Mu H, Mak D, Kornblau S, Zhang Q, Ruvolo P, Burks JK, Zhang W, McQueen T, Pan R, Zhou H, Konopleva M, Cortes JE, Liu Q, et al. Disruption of Wnt/β-catenin exerts anti-leukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29463558 DOI: 10.1158/1078-0432.Ccr-17-1556 |
0.053 |
|
| 2015 |
Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, Andreeff M, Woodward WA, Dadbin A, Kolonin MG, Lu KH, Klopp AH. Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. Plos One. 10: e0136361. PMID 26317219 DOI: 10.1371/Journal.Pone.0136361 |
0.053 |
|
| 2023 |
Sans M, Makino Y, Min J, Rajapakshe KI, Yip-Schneider M, Schmidt CM, Hurd MW, Burks JK, Gomez JA, Thege FI, Fahrmann JF, Wolff RA, Kim MP, Guerrero PA, Maitra A. Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of The Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential. Cancer Discovery. PMID 37285225 DOI: 10.1158/2159-8290.CD-22-1200 |
0.05 |
|
| 2017 |
Ten Hacken E, Gounari M, Back JW, Shimanovskaya E, Scarfo L, Kim E, Burks J, Ponzoni M, Ramirez GA, Wierda WG, Estrov Z, Keating MJ, Ferrajoli A, Stamatopoulos K, Ghia P, et al. Calreticulin as a novel B cell receptor antigen in chronic lymphocytic leukemia. Haematologica. PMID 28751563 DOI: 10.3324/haematol.2017.169102 |
0.05 |
|
| 2022 |
Quesada PR, Riquelme E, Burks J, Rakoski A, Sahin I, McAllister F. Assessment of the Murine Tumor Microenvironment by Multiplex Immunofluorescence. Methods in Molecular Biology (Clifton, N.J.). 2435: 107-127. PMID 34993942 DOI: 10.1007/978-1-0716-2014-4_8 |
0.05 |
|
| 2024 |
Hoke ATK, Takahashi Y, Padget MR, Gomez J, Amit M, Burks J, Bell D, Xie T, Soon-Shiong P, Hodge JW, Hanna EY, London NR. Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach. Translational Oncology. 44: 101943. PMID 38593586 DOI: 10.1016/j.tranon.2024.101943 |
0.049 |
|
| 2011 |
Andreeff M, Battula VL, Wang R, Chen Y, Ling X, Jacamo R, Spaeth E, Konoplev S, Burks J, Hazen A, Schober W, Lu H, Mak D, McQueen T, Shi Y, et al. 900 Multipotent Mesenchymal Stromal Cells (MSC) - Evolving Role in Cancer and Leukemia Therapy Clinical Lymphoma Myeloma and Leukemia. 11: S134-S135. DOI: 10.1016/J.Clml.2011.05.033 |
0.048 |
|
| 2015 |
Borthakur G, Duvvuri S, Ruvolo V, Tripathi DN, Piya S, Burks J, Jacamo R, Kojima K, Ruvolo P, Fueyo-Margareto J, Konopleva M, Andreeff M. MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation. Plos One. 10: e0139254. PMID 26440941 DOI: 10.1371/journal.pone.0139254 |
0.047 |
|
| 2022 |
Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, et al. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. The Journal of Clinical Investigation. PMID 36282600 DOI: 10.1172/JCI151604 |
0.047 |
|
| 2022 |
Amit M, Xie T, Gleber-Netto FO, Hunt PJ, Mehta GU, Bell D, Silverman DA, Yaman I, Ye Y, Burks JK, Fuller GN, Gidley PW, Nader ME, Raza SM, DeMonte F. Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. Journal of Experimental & Clinical Cancer Research : Cr. 41: 292. PMID 36195959 DOI: 10.1186/s13046-022-02473-4 |
0.047 |
|
| 2022 |
Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, ... ... Burks JK, et al. Central nervous system immune interactome is function of cancer lineage, tumor microenvironment and STAT3 expression. Jci Insight. PMID 35316217 DOI: 10.1172/jci.insight.157612 |
0.046 |
|
| 2020 |
Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler DB, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski R, Burks JK, Long JP, et al. Radiation with STAT3 blockade triggers dendritic cell-T cell interactions in the glioma microenvironment and therapeutic efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32605912 DOI: 10.1158/1078-0432.Ccr-19-4092 |
0.046 |
|
| 2022 |
Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, ... ... Burks JK, et al. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 40: 509-523.e6. PMID 35537412 DOI: 10.1016/j.ccell.2022.04.004 |
0.044 |
|
| 2018 |
Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Research and Treatment. PMID 29858753 DOI: 10.1007/S10549-018-4835-6 |
0.043 |
|
| 2022 |
Sousa LG, McGrail DJ, Li K, Marques-Piubelli ML, Gonzalez C, Dai H, Ferri-Borgogno S, Godoy M, Burks J, Lin SY, Bell D, Ferrarotto R. Spontaneous tumor regression following COVID-19 vaccination. Journal For Immunotherapy of Cancer. 10. PMID 35241495 DOI: 10.1136/jitc-2021-004371 |
0.043 |
|
| 2020 |
Zhang Y, Chandra V, Riquelme Sanchez E, Dutta P, Quesada PR, Rakoski A, Zoltan M, Arora N, Baydogan S, Horne W, Burks J, Xu H, Hussain P, Wang H, Gupta S, et al. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. The Journal of Experimental Medicine. 217. PMID 32860704 DOI: 10.1084/jem.20190354 |
0.037 |
|
| 2021 |
Corvigno S, Burks JK, Hu W, Zhong Y, Jennings NB, Fleming ND, Westin SN, Fellman B, Liu J, Sood AK. Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status. Journal of Cancer Research and Clinical Oncology. PMID 34476576 DOI: 10.1007/s00432-021-03778-1 |
0.036 |
|
| 2022 |
Fukuda Y, Bustos MA, Cho SN, Roszik J, Ryu S, Lopez VM, Burks JK, Lee JE, Grimm EA, Hoon DSB, Ekmekcioglu S. Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma. Cell Death & Disease. 13: 422. PMID 35501311 DOI: 10.1038/s41419-022-04879-6 |
0.036 |
|
| 2015 |
Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, et al. PD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. PMID 26323609 DOI: 10.1093/neuonc/nov172 |
0.035 |
|
| 2023 |
Saldarriaga OA, Wanninger TG, Arroyave E, Gosnell J, Krishnan S, Oneka M, Bao D, Millian DE, Kueht ML, Moghe A, Jiao J, Sanchez JI, Spratt H, Beretta L, Rao A, ... Burks JK, et al. Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis. Jhep Reports : Innovation in Hepatology. 6: 100958. PMID 38162144 DOI: 10.1016/j.jhepr.2023.100958 |
0.031 |
|
| 2016 |
Liu S, Anfossi S, Qiu B, Zheng Y, Cai M, Fu J, Yang H, Liu Q, Chen Z, Fu J, Liu M, Burks JK, Lin SH, Reuben J, Liu H. Prognostic Factors for Locoregional Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma Treated with Radical Two-Field Lymph Node Dissection: Results from Long-Term Follow-Up. Annals of Surgical Oncology. PMID 27804027 DOI: 10.1245/s10434-016-5652-y |
0.03 |
|
| 2016 |
Liu S, Anfossi S, Zheng Y, Cai M, Fu J, Qiu B, Yang H, Liu Q, Fu J, Liu M, Burks JK, Lin SH, Reuben J, Liu H. Clinical and Biological Prognostic Factors for Locoregional Recurrence in Patients With Thoracic Esophageal Squamous Cell Carcinoma Treated With Radical 2-field Lymph Node Dissection: Results From Long-term Follow-up. International Journal of Radiation Oncology, Biology, Physics. 96: E175. PMID 27673975 DOI: 10.1016/j.ijrobp.2016.06.1030 |
0.029 |
|
| 2015 |
Han L, Rowinsky E, Brooks C, Shi C, Zhang Q, Burks J, Zhou J, Mu H, Ciurea SO, Alatrash G, Cortes J, Kantarjian HM, Andreeff M, Ravandi F, Konopleva M. Anti-leukemia efficacy and mechanisms of action of SL-101, a novel anti-CD123 antibody-conjugate in acute myeloid leukemia Clinical Lymphoma Myeloma and Leukemia. 15: S14. DOI: 10.1016/j.clml.2015.07.033 |
0.027 |
|
| 2019 |
Chattopadhyay C, Oba J, Roszik J, Marszalek JR, Chen K, Qi Y, Eterovic K, Robertson AG, Burks JK, McCannel TA, Grimm EA, Woodman SE. Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma. Investigative Ophthalmology & Visual Science. 60: 4187-4195. PMID 31596927 DOI: 10.1167/Iovs.19-28082 |
0.024 |
|
| 2015 |
Nduom EK, Wei J, Yaghi N, Huang N, Kong L, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks J, Fuller G, Calin G, Conrad C, Creasy C, et al. IMPS-28PD-L1 EXPRESSION AND PROGNOSTIC IMPACT IN GLIOBLASTOMA Neuro-Oncology. 17: v119.2-v119. DOI: 10.1093/neuonc/nov217.27 |
0.02 |
|
| 2014 |
Takiar V, Burks J, Sulman E, Ramondetta L, Jhingran A, Deavers M, Eifel P, Klopp A. PD-1 Levels Correlate With Lymph Node Positivity in Patients With Squamous Cell Carcinoma of the Cervix International Journal of Radiation Oncology*Biology*Physics. 90: S479-S480. DOI: 10.1016/J.Ijrobp.2014.05.1487 |
0.02 |
|
| 2018 |
Morita K, Wang F, Yan Y, Burks J, Gumbs C, Latasha L, Tippen S, Thornton R, Coyle M, Zhang J, Xingzhi S, DiNardo C, Jabbour E, Andreeff M, Cortes J, et al. The Landscape of Genotype-Phenotype Correlation in AML Clinical Lymphoma Myeloma and Leukemia. 18: S209-S210. DOI: 10.1016/J.Clml.2018.07.066 |
0.019 |
|
| 2018 |
Kassab C, Levine J, Boudreau B, Ling X, Burks JK, Zhou S, Verhaak R, Heimberger A. IMMU-36. IMMUNE RESPONSES IN CANINE GLIOMAS ARE ENRICHED AT THE INFILTRATING EDGE OF ASTROCYTOMAS Neuro-Oncology. 20: vi129-vi129. DOI: 10.1093/neuonc/noy148.539 |
0.018 |
|
| 2019 |
Burks JK. Mass Cytometry Why Multiplex. Journal of Biomolecular Techniques : Jbt. 30: S54. PMID 31897006 |
0.015 |
|
| 2022 |
Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, ... ... Burks JK, et al. Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature Cancer. PMID 35149861 DOI: 10.1038/s43018-022-00343-8 |
0.012 |
|
| 2020 |
Lee S, Zhao L, Rojas C, Bateman N, Yao H, Lara O, Jazaeri A, Liu J, Burks J, Fleming N, Lu K, Westin S, Coleman R, Mills G, Zhang J, et al. A high-depth multi-omics analysis of clinically defined subsets of high-grade serous ovarian cancer Gynecologic Oncology. 159: 77. DOI: 10.1016/j.ygyno.2020.06.163 |
0.01 |
|
| Hide low-probability matches. |